Advertisement: Excalibur Healthcare mid banner
Advertisement: Bar Ellison mid banner property
Advertisement: EBCam mid banner
Mid banner advertisement: BDO
Advertisement: RSM mid banner
Advertisement: SATAVIA mid banner
Advertisement: Wild Knight Vodka
Advertisement: HCR Hewitsons mid banner
Advertisement: Mogrify mid banner
Barr Ellison Solicitors – commercial property
Advertisement: CJBS mid banner
Cambridgeand mid banner advertisement
Advertisement: Cambridge Network mid banner
Advertisement: Simpsons Creative
Advertisement: TTP
Advertisement: partnersand mid banner
Advertisement: Kao Data Centre mid banner
Advertisement: S-Tech mid banner 3
ARM Innovation Hub
13 December, 2021 - 09:59 By Tony Quested

Tristel goes global to cut exposure to NHS

Infection prevention specialist Tristel plc is ramping exports to reduce exposure to the NHS, CEO Paul Swinney told the annual meeting in Newmarket.

Allied to an encouraging trading update, the UK share price opened slightly higher at 489p.

Swinney told shareholders: “As the half progressed, in all our geographical markets sales have picked-up well as hospitals have gradually returned to normal service levels for diagnostic procedures. 

“We expect revenue to exceed £15 million compared to £16.8m in the first half last year, noting revenue last year included a one-off sale of £0.9m to the NHS for Brexit-related inventory. 

“This stock was released back to UK hospitals during this first half, creating a £1.8m period-on-period distortion. Overseas revenues are expected to account for 64 per cent of worldwide sales during the half compared to 60 per cent in the comparable period last year. 

“Reducing our exposure to the UK NHS by growing our existing overseas businesses and entering new geographical markets is a key objective for the company.

“Cash after the full-year dividend sits above £8m. Based on continued normalisation of hospital procedure numbers in the UK and elsewhere, which is clearly dependent on Covid-related updates, we are on track at this stage to be in line with market expectations for the year.”

Newsletter Subscription

Stay informed of the latest news and features